Use of herbal preparations in the treatment of oxidant-mediated inflammatory disorders

Complementary Therapies in Medicine

Volumn 15, Issue 3, 2007, Pages 207-216

  Kaplan, Mitchell ^a   Mutlu, Ece A ^a   Benson, Mark ^a   Fields, Jeremy Z ^a   Banan, Ali ^a   Keshavarzian, Ali ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTOCARPUS HETEROPHYLLUS EXTRACT; CATALASE; CURCUMA LONGA EXTRACT; GARLIC EXTRACT; GINGER EXTRACT; GINKGO BILOBA EXTRACT; GINKGOLIDE; GINKGOLIDE B; GINSENG EXTRACT; GLUTATHIONE PEROXIDASE; GLYCYRRHIZA GLABRA EXTRACT; GREEN TEA EXTRACT; HERBACEOUS AGENT; INTERLEUKIN 1; LEUKOTRIENE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MAGNOLIA OBOVATA EXTRACT; NITRIC OXIDE; PLACEBO; PLANT EXTRACT; PROSTAGLANDIN; REACTIVE OXYGEN METABOLITE; SCUTELLARIA BAICALENSIS EXTRACT; SUPEROXIDE DISMUTASE; THROMBOCYTE ACTIVATING FACTOR; TRIPTERYGIUM WILFORDII EXTRACT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ALTERNATIVE MEDICINE; ALZHEIMER DISEASE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; ARTOCARPUS HETEROPHYLLUS; ASTHMA; ATHEROSCLEROSIS; BREADFRUIT; CLINICAL TRIAL; DIARRHEA; DRUG HYPERSENSITIVITY; DRUG MECHANISM; ENTERITIS; HEADACHE; HERBAL MEDICINE; HUMAN; INFLAMMATORY DISEASE; MAGNOLIA OBOVATA; MAGNOLIACEAE; NAUSEA; OXIDATIVE STRESS; PATHOGENESIS; RHEUMATOID ARTHRITIS; SKIN MANIFESTATION; TREATMENT OUTCOME; TRIPTERYGIUM; TRIPTERYGIUM WILFORDII;

ALZHEIMER DISEASE; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; ARTHRITIS, RHEUMATOID; ASTHMA; ATHEROSCLEROSIS; CLINICAL TRIALS; HUMANS; INFLAMMATION; INFLAMMATORY BOWEL DISEASES; MEDICINE, HERBAL; PHYTOTHERAPY; PLANT PREPARATIONS; REACTIVE OXYGEN SPECIES;

EID: 34547875777     PISSN: 09652299     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ctim.2006.06.005     Document Type: Article

References (94)

1. Eisenberg D.M., Davis R.B., Ettner S.L., et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA 280 (1998) 1569-1575
2. Craig W.J. Health-promoting properties of common herbs. Am J Clin Nutr 70 (1999) 491S-499S
3. Nelson L., and Perrone J. Herbal and alternative medicine. Emerg Med Clin North Am 18 (2000) 709-722
4. Davies M.G., and Hagen P.O. Systemic inflammatory response syndrome. Br J Surg 84 (1997) 920-935
5. Conner E.M., and Grisham M.B. Inflammation, free radicals, and antioxidants. Nutrition 12 (1996) 274-277
6. Siebenlist U., Franzoso G., and Brown K. Structure, regulation and function of NF-kappa B. Annu Rev Cell Biol 10 (1994) 405-455
7. Schreck R., Albermann K., and Baeuerle P.A. Nuclear factor kappa B: an oxidative stress-responsive transcription factor of eukaryotic cells (a review). Free Radic Res Commun 17 (1992) 221-237
8. Halliwell B. Free radicals, antioxidants, and human disease: curiosity, cause, or consequence?. Lancet 344 (1994) 721-724
9. Surh Y. Molecular mechanisms of chemopreventive effects of selected dietary and medicinal phenolic substances. Mutat Res 428 (1999) 305-327
10. Shanmugasundaram K.R., Kumar S.S., and Rajajee S. Excessive free radical generation in the blood of children suffering from asthma. Clin Chim Acta 305 (2001) 107-114
11. Kanazawa H., Kurihara N., Hirata K., and Takeda T. The role of free radicals in airway obstruction in asthmatic patients. Chest 100 (1991) 1319-1322
12. Bielory L., and Lupoli K. Herbal interventions in asthma and allergy. J Asthma 36 (1999) 1-65
13. Freeman B.A., and Crapo J.D. Biology of disease: free radicals and tissue injury. Lab Invest 47 (1982) 412-426
14. Jarjour N.N., and Calhoun W.J. Enhanced production of oxygen radicals in asthma. J Lab Clin Med 123 (1994) 131-136
15. Babior B.M. The respiratory burst of phagocytes. J Clin Invest 73 (1984) 599-601
16. Sporn P.H., Peters-Golden M., and Simon R.H. Hydrogen-peroxide-induced arachidonic acid metabolism in the rat alveolar macrophage. Am Rev Respir Dis 137 (1988) 49-56
17. Katsumata U., Miura M., Ichinose M., et al. Oxygen radicals produce airway constriction and hyperresponsiveness in anesthetized cats. Am Rev Respir Dis 141 (1990) 1158-1161
18. Odeh M. New insights into the pathogenesis and treatment of rheumatoid arthritis. Clin Immunol Immunopathol 83 (1997) 103-116
19. Brennan F.M., Field M., Chu C.Q., Feldmann M., and Maini R.N. Cytokine expression in rheumatoid arthritis. Br J Rheumatol 30 Suppl. 1 (1991) 76-80
20. Stefanovic-Racic M., Stadler J., and Evans C.H. Nitric oxide and arthritis. Arthritis Rheum 36 (1993) 1036-1044
21. Pitchumoni S.S., and Doraiswamy P.M. Current status of antioxidant therapy for Alzheimer's Disease. J Am Geriatr Soc 46 (1998) 1566-1572
22. Behl C., Davis J., Cole G.M., and Schubert D. Vitamin E protects nerve cells from amyloid beta protein toxicity. Biochem Biophys Res Commun 186 (1992) 944-950
23. Witztum J.L., and Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest 88 (1991) 1785-1792
24. Aviram M. Modified forms of low density lipoprotein and atherosclerosis. Atherosclerosis 98 (1993) 1-9
25. Chan P., and Tomlinson B. Antioxidant effects of Chinese traditional medicine: focus on trilinolein isolated from the Chinese herb sanchi (Panax pseudoginseng). J Clin Pharmacol 40 (2000) 457-461
26. Aviram M. Oxidative modification of low density lipoprotein and its relation to atherosclerosis. Isr J Med Sci 31 (1995) 241-249
27. Fuhrman B., Buch S., Vaya J., et al. Licorice extract and its major polyphenol glabridin protect low-density lipoprotein against lipid peroxidation: in vitro and ex vivo studies in humans and in atherosclerotic apolipoprotein E-deficient mice. Am J Clin Nutr 66 (1997) 267-275
28. Andres P.G., and Friedman L.S. Epidemiology and the natural course of inflammatory bowel disease. Gastroenterol Clin North Am 28 (1999) 255-281 vii
29. Nassif A., Longo W.E., Mazuski J.E., Vernava A.M., and Kaminski D.L. Role of cytokines and platelet-activating factor in inflammatory bowel disease. Implications for therapy. Dis Colon Rectum 39 (1996) 217-223
30. Papadakis K.A., and Targan S.R. Current theories on the causes of inflammatory bowel disease. Gastroenterol Clin North Am 28 (1999) 283-296
31. Babbs C.F. Oxygen radicals in ulcerative colitis. Free Radic Biol Med 13 (1992) 169-181
32. Keshavarzian A., Sedghi S., Kanofsky J., et al. Excessive production of reactive oxygen metabolites by inflamed colon: analysis by chemiluminescence probe. Gastroenterology 103 (1992) 177-185
33. Simmonds N.J., Allen R.E., Stevens T.R., Van Someren R.N., Blake D.R., and Rampton D.S. Chemiluminescence assay of mucosal reactive oxygen metabolites in inflammatory bowel disease. Gastroenterology 103 (1992) 186-196
34. Grisham M.B., Volkmer C., Tso P., and Yamada T. Metabolism of trinitrobenzene sulfonic acid by the rat colon produces reactive oxygen species. Gastroenterology 101 (1991) 540-547
35. Millar A.D., Rampton D.S., Chander C.L., et al. Evaluating the antioxidant potential of new treatments for inflammatory bowel disease using a rat model of colitis. Gut 39 (1996) 407-415
36. Grisham M.B., MacDermott R.P., and Deitch E.A. Oxidant defense mechanisms in the human colon. Inflammation 14 (1990) 669-680
37. Sido B., Hack V., Hochlehnert A., Lipps H., Herfarth C., and Droge W. Impairment of intestinal glutathione synthesis in patients with inflammatory bowel disease. Gut 42 (1998) 485-492
38. Lih-Brody L., Powell S.R., Collier K.P., et al. Increased oxidative stress and decreased antioxidant defenses in mucosa of inflammatory bowel disease. Dig Dis Sci 41 (1996) 2078-2086
39. Holmes E.W., Yong S.L., Eiznhamer D., and Keshavarzian A. Glutathione content of colonic mucosa: evidence for oxidative damage in active ulcerative colitis. Dig Dis Sci 43 (1998) 1088-1095
40. Nieto N., Torres M.I., Fernandez M.I., et al. Experimental ulcerative colitis impairs antioxidant defense system in rat intestine. Dig Dis Sci 45 (2000) 1820-1827
41. Grisham M.B. Oxidants and free radicals in inflammatory bowel disease. Lancet 344 (1994) 859-861
42. Gross V., Arndt H., Andus T., Palitzsch K.D., and Scholmerich J. Free radicals in inflammatory bowel diseases pathophysiology and therapeutic implications. Hepatogastroenterology 41 (1994) 320-327
43. Rao R., Baker R.D., and Baker S.S. Inhibition of oxidant-induced barrier disruption and protein tyrosine phosphorylation in Caco-2 cell monolayers by epidermal growth factor. Biochem Pharmacol 57 (1999) 685-695
44. Banan A., Choudhary S., Zhang Y., Fields J.Z., and Keshavarzian A. Ethanol-induced barrier dysfunction and its prevention by growth factors in human intestinal monolayers: evidence for oxidative and cytoskeletal mechanisms. J Pharmacol Exp Ther 291 (1999) 1075-1085
45. Banan A., Choudhary S., Zhang Y., Fields J.Z., and Keshavarzian A. Oxidant-induced intestinal barrier disruption and its prevention by growth factors in a human colonic cell line: role of the microtubule cytoskeleton. Free Radic Biol Med 28 (2000) 727-738
46. Bellomo G., Mirabelli F., Vairetti M., Iosi F., and Malorni W. Cytoskeleton as a target in menadione-induced oxidative stress in cultured mammalian cells. I. Biochemical and immunocytochemical features. J Cell Physiol 143 (1990) 118-128
47. Ko F.N., Cheng Z.J., Lin C.N., and Teng C.M. Scavenger and antioxidant properties of prenylflavones isolated from Artocarpus heterophyllus. Free Radic Biol Med 25 (1998) 160-168
48. Rabinkov A., Miron T., Konstantinovski L., Wilchek M., Mirelman D., and Weiner L. The mode of action of allicin: trapping of radicals and interaction with thiol containing proteins. Biochim Biophys Acta 1379 (1998) 233-244
49. Geng Z., Rong Y., and Lau B.H. S-allyl cysteine inhibits activation of nuclear factor kappa B in human T cells. Free Radic Biol Med 23 (1997) 345-350
50. Kim K.M., Chun S.B., Koo M.S., et al. Differential regulation of NO availability from macrophages and endothelial cells by the garlic component S-allyl cysteine. Free Radic Biol Med 30 (2001) 747-756
51. Hibatallah J., Carduner C., and Poelman M.C. In-vivo and in-vitro assessment of the free-radical-scavenger activity of Ginkgo flavone glycosides at high concentration. J Pharm Pharmacol 51 (1999) 1435-1440
52. Kobuchi H., Droy-Lefaix M.T., Christen Y., and Packer L. Ginkgo biloba extract (EGb 761): inhibitory effect on nitric oxide production in the macrophage cell line RAW 264.7. Biochem Pharmacol 53 (1997) 897-903
53. Marcocci L., Maguire J.J., Droy-Lefaix M.T., and Packer L. The nitric oxide-scavenging properties of Ginkgo biloba extract EGb 761. Biochem Biophys Res Commun 201 (1994) 748-755
54. Desquand S., Touvay C., Randon J., et al. Interference of BN 52021 (ginkgolide B) with the bronchopulmonary effects of PAF-acether in the guinea-pig. Eur J Pharmacol 127 (1986) 83-95
55. Haraguchi H., Ishikawa H., Shirataki N., and Fukuda A. Antiperoxidative activity of neolignans from Magnolia obovata. J Pharm Pharmacol 49 (1997) 209-212
56. Hong C.Y., Huang S.S., and Tsai S.K. Magnolol reduces infarct size and suppresses ventricular arrhythmia in rats subjected to coronary ligation. Clin Exp Pharmacol Physiol 23 (1996) 660-664
57. Shen Y.C., Sung Y.J., and Chen C.F. Magnolol inhibits Mac-1 (CD11b/CD18)-dependent neutrophil adhesion: relationship with its antioxidant effect. Eur J Pharmacol 343 (1998) 79-86
58. Zhang D., Yasuda T., Yu Y., et al. Ginseng extract scavenges hydroxyl radical and protects unsaturated fatty acids from decomposition caused by iron-mediated lipid peroxidation. Free Radic Biol Med 20 (1996) 145-150
59. Liu J., Yang C.F., Lee B.L., Shen H.M., Ang S.G., and Ong C.N. Effect of Salvia miltiorrhiza on aflatoxin B1-induced oxidative stress in cultured rat hepatocytes. Free Radic Res 31 (1999) 559-568
60. Zhao B.L., Jiang W., Zhao Y., Hou J.W., and Xin W.J. Scavenging effects of Salvia miltiorrhiza on free radicals and its protection for myocardial mitochondrial membranes from ischemia-reperfusion injury. Biochem Mol Biol Int 38 (1996) 1171-1182
61. Shao Z.H., Li C.Q., Vanden Hoek T.L., et al. Extract from Scutellaria baicalensis Georgi attenuates oxidant stress in cardiomyocytes. J Mol Cell Cardiol 31 (1999) 1885-1895
62. Chen Y., Yang L., and Lee T.J. Oroxylin A inhibition of lipopolysaccharide-induced iNOS and COX-2 gene expression via suppression of nuclear factor-kappaB activation. Biochem Pharmacol 59 (2000) 1445-1457
63. Tao X., Ma L., Mao Y., and Lipsky P.E. Suppression of carrageenan-induced inflammation in vivo by an extract of the Chinese herbal remedy Tripterygium wilfordii Hook F. Inflamm Res 48 (1999) 139-148
64. Sreejayan, and Rao M.N. Nitric oxide scavenging by curcuminoids. J Pharm Pharmacol 49 (1997) 105-107
65. Chan M.M., Huang H.I., Fenton M.R., and Fong D. In vivo inhibition of nitric oxide synthase gene expression by curcumin, a cancer preventive natural product with anti-inflammatory properties. Biochem Pharmacol 55 (1998) 1955-1962
66. Huang M.T., Lou Y.R., Ma W., Newmark H.L., Reuhl K.R., and Conney A.H. Inhibitory effects of dietary curcumin on forestomach, duodenal, and colon carcinogenesis in mice. Cancer Res 54 (1994) 5841-5847
67. Li M.H., Zhang H.L., and Yang B.Y. Effects of ginkgo leave concentrated oral liquor in treating asthma. Zhongguo Zhong Xi Yi Jie He Za Zhi 17 (1997) 216-218
68. Henderson C.J., and Panush R.S. Diets, dietary supplements, and nutritional therapies in rheumatic diseases. Rheum Dis Clin North Am 25 (1999) 937-968 ix
69. Srivastava K.C., and Mustafa T. Ginger (Zingiber officinale) in rheumatism and musculoskeletal disorders. Med Hypotheses 39 (1992) 342-348
70. Altman R.D., and Marcussen K.C. Effects of a ginger extract on knee pain in patients with osteoarthritis. Arthritis Rheum 44 (2001) 2531-2538
71. Tao X., Younger J., Fan F.Z., Wang B., and Lipsky P.E. Benefit of an extract of Tripterygium wilfordii Hook F in patients with rheumatoid arthritis: a double-blind, placebo-controlled study. Arthritis Rheum 46 (2002) 1735-1743
72. McCarthy G.M., and McCarty D.J. Effect of topical capsaicin in the therapy of painful osteoarthritis of the hands. J Rheumatol 19 (1992) 604-607
73. Belch J.J., Ansell D., Madhok R., O'Dowd A., and Sturrock R.D. Effects of altering dietary essential fatty acids on requirements for non-steroidal anti-inflammatory drugs in patients with rheumatoid arthritis: a double blind placebo controlled study. Ann Rheum Dis 47 (1988) 96-104
74. Jenner P. Oxidative damage in neurodegenerative disease. Lancet 344 (1994) 796-798
75. Beal M.F. Aging, energy, and oxidative stress in neurodegenerative diseases. Ann Neurol 38 (1995) 357-366
76. Gale C.R., Martyn C.N., and Cooper C. Cognitive impairment and mortality in a cohort of elderly people. BMJ 312 (1996) 608-611
77. Goodwin J.S., Goodwin J.M., and Garry P.J. Association between nutritional status and cognitive functioning in a healthy elderly population. JAMA 249 (1983) 2917-2921
78. La Rue A., Koehler K.M., Wayne S.J., Chiulli S.J., Haaland K.Y., and Garry P.J. Nutritional status and cognitive functioning in a normally aging sample: a 6-year reassessment. Am J Clin Nutr 65 (1997) 20-29
79. Perrig W.J., Perrig P., and Stahelin H.B. The relation between antioxidants and memory performance in the old and very old. J Am Geriatr Soc 45 (1997) 718-724
80. Le Bars P.L., Katz M.M., Berman N., Itil T.M., Freedman A.M., and Schatzberg A.F. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group. JAMA 278 (1997) 1327-1332
81. Kanowski S., Herrmann W.M., Stephan K., Wierich W., and Horr R. Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia. Pharmacopsychiatry 29 (1996) 47-56
82. Schulz V., Hansel R., and Tyler V. Rational phytotherapy: a physicians guide to herbal medicine (1997), Springer-Verlag, New York, NY
83. Rowin J., and Lewis S.L. Spontaneous bilateral subdural hematomas associated with chronic Ginkgo biloba ingestion. Neurology 46 (1996) 1775-1776
84. Matthews Jr. M.K. Association of Ginkgo biloba with intracerebral hemorrhage. Neurology 50 (1998) 1933-1934
85. Mashour N.H., Lin G.I., and Frishman W.H. Herbal medicine for the treatment of cardiovascular disease: clinical considerations. Arch Intern Med 158 (1998) 2225-2234
86. Bordia A. Effect of garlic on blood lipids in patients with coronary heart disease. Am J Clin Nutr 34 (1981) 2100-2103
87. Warshafsky S., Kamer R.S., and Sivak S.L. Effect of garlic on total serum cholesterol. A meta-analysis. Ann Intern Med 119 (1993) 599-605
88. Stevinson C., Pittler M.H., and Ernst E. Garlic for treating hypercholesterolemia. A meta-analysis of randomized clinical trials. Ann Intern Med 133 (2000) 420-429
89. Fuhrman B., Volkova N., Kaplan M., et al. Antiatherosclerotic effects of licorice extract supplementation on hypercholesterolemic patients: increased resistance of LDL to atherogenic modifications, reduced plasma lipid levels, and decreased systolic blood pressure. Nutrition 18 (2002) 268-273
90. Sugimoto K., Hanai H., Tozawa K., et al. Curcumin prevents and ameliorates trinitrobenzene sulfonic acid-induced colitis in mice. Gastroenterology 123 (2002) 1912-1922
91. Varilek G.W., Yang F., Lee E.Y., et al. Green tea polyphenol extract attenuates inflammation in interleukin-2-deficient mice, a model of autoimmunity. J Nutr 131 (2001) 2034-2039
92. Heuschkel R., Afzal N., Wuerth A., et al. Complementary medicine use in children and young adults with inflammatory bowel disease. Am J Gastroenterol 97 (2002) 382-388
93. Chen Z.S., Nie Z.W., and Sun Q.L. Clinical study in treating intractable ulcerative colitis with traditional Chinese medicine. Zhongguo Zhong Xi Yi Jie He Za Zhi 14 (1994) 400-402
94. Mutlu E., Mikolaitis S., Polzin L., et al. A complementary and alternative medicine (CAM) treatment program for IBD patients. Am Coll Gastroenterol (2002) 174